LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 50 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $25,740,000 | -6.5% | 3,455,044 | -12.8% | 6.10% | -40.4% |
| Q4 2016 | $27,522,000 | +3.5% | 3,959,944 | +22.6% | 10.24% | +2.5% |
| Q3 2016 | $26,582,000 | +1.5% | 3,229,916 | -0.1% | 9.98% | -20.7% |
| Q2 2016 | $26,183,000 | +106.2% | 3,232,416 | +29.3% | 12.58% | +77.2% |
| Q1 2016 | $12,700,000 | -14.1% | 2,500,000 | +30.5% | 7.10% | +0.4% |
| Q4 2015 | $14,784,000 | +95.2% | 1,915,000 | +45.6% | 7.07% | +61.3% |
| Q3 2015 | $7,574,000 | -6.8% | 1,314,959 | +48.4% | 4.38% | -12.7% |
| Q2 2015 | $8,125,000 | +0.3% | 886,000 | +32.4% | 5.02% | -26.4% |
| Q1 2015 | $8,104,000 | – | 669,196 | – | 6.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
| Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
| FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
| Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
| Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
| Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
| Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
| QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
| Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |